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BSTRACT
Background:
 
Neuropeptides are considered to be
factors that trigger, exacerbate or modulate allergic
diseases and inflammatory skin reactions. In addition,
it has been indicated that allergic diseases are highly
correlated with stress.
 
Methods:
 
2,4,6-Trinitrochlorbenzene (TNCB) and
crowding stress were applied to mouse atopic dermati-
tis (AD) models for the purpose of provoking chronic
dermatitis. In addition, TNCB-sensitized mice were
given olopatadine hydrochloride (10 or 3 mg/kg), an
anti-allergic agent, orally. The neuropeptide content in
the skin tissues and serum IgE levels were measured
in these mice.
 
Results:
 
Repeated local application of TNCB solution
induced itching skin lesions, together with an increase
in levels of substance P, a decrease in calcitonin gene-
related peptide levels and early augmentation of IgE
production. Treatment with crowding stress brought
about a transient increase in substance P. Further-
more, we observed significant decreases in substance
P and serum IgE levels when the administration of
olopatadine hydrochloride was started before the
elicitation of chronic dermatitis caused by repeated
application of TNCB solution. These changes were
more definite in the group administered a higher dose
of the drug (10 mg/kg).
 
Conclusions:
 
It is suggested that repeated contact
allergic dermatitis or mental stress may promote the
development and exacerbation of AD and that sub-
stance P has a role in this response. In addition, it
seems that an anti-allergic drug, such as olopatadine
hydrochloride, possibly downregulates substance P,
thereby suppressing the development of AD. In the
future, the development and clinical application of a
drug that strongly influences the release of neuro-
peptides, such as substance P, and the expression of
neuropeptide receptors would be expected for the
treatment of AD.
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I
 
NTRODUCTION
 
Sensory and autonomic nerves are widely distributed
in the skin, together with more than 20 types of
neuropeptides. Neuropeptides do not simply act as
neurotransmitters or neuromodulators, but also exhibit
diverse physiological activities in the skin. They are
considered to be factors that trigger, exacerbate or
modulate allergic diseases. In addition, it is indicated
that allergic diseases are highly correlated with
stress.
 
1–3
 
In the present study, we measured the neuropeptide
contents of skin tissues and serum IgE levels in mouse
atopic dermatitis (AD) models, with the aim of investigat-
ing the involvement of neuropeptides in the development
and exacerbation of AD, as well as the factors affecting
neuropeptide content.
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M
 
ETHODS
 
Experimental animals
 
Female NC/Nga mice aged 7–11 weeks and raised
in specific pathogen-free (SPF) conditions were pur-
chased from Japan SLC (Shizuoka, Japan). Five week-
old female DS-Nh mice raised in SPF conditions
(Shionogi, Pharmaceutical Research and Development
Division, Osaka, Japan) were acclimatized under
conventional conditions before being used in the
experiments.
The animal room was controlled at a temperature
of 23 
 
±
 
 3
 
°
 
C, 55 
 
±
 
 10% humidity and a 12 h light–dark
cycle. Animals were kept in cages lined with sterilized
sawdust and were given sterilized solid feed (CE-2; CLEA
Japan, Tokyo, Japan) and water 
 
ad libitum
 
.
 
Drugs and reagents
 
Olopatadine hydrochloride (Kyowa Hakko Kogyo,
Tokyo, Japan), which was used as the test drug, was
dissolved in distilled water. A 1% solution of the sensi-
tizing antigen 2,4,6-trinitrochlorbenzene (TNCB) was
made in a solvent of acetone : olive oil (4 : 1) and used
in the experiments.
 
Sensitization and elicitation of chronic 
dermatitis
 
2,4,6-Trinitrochlorbenzene (100 
 
µ
 
L of a 1% solution)
was applied to the dorsal skin of NC/Nga and DS-Nh
mice for sensitization. Seven days after sensitization,
50 
 
µ
 
L of the same solution was applied to the skin of the
same area to induce skin lesions. Thereafter, 50 
 
µ
 
L of
the same solution was applied repeatedly to the same
skin area every other day (48 h intervals) for the purpose
of provoking chronic dermatitis.
 
Stress treatment
 
Female NC/Nga mice raised under SPF conditions were
purchased at 7 weeks of age and housed 6 per cage in
cages intended for 10 mice until 12 weeks of age. After
reaching 12 weeks of age, mice were housed 12 per
cage in cages intended for five mice to produce crowd-
ing stress. Skin biopsies and blood collections were
performed before stress treatment and after 2, 4, 7 and
13 days under stress.
 
Olopatadine administration
 
The TNCB-sensitized DS-Nh mice were administered
olopatadine hydrochloride, an anti-allergic agent,
orally using a stomach tube 5 days a week for 2 weeks.
Mice were allocated to either a 10 or 3 mg/kg group.
Olopatadine hydrochloride was dissolved in 150 
 
µ
 
L
distilled water and administered to the TNCB-treated
groups. Control mice were administered the same
volume of distilled water. The effect of olopatadine
hydrochloride in mice was compared between groups
in which drug administration was started either 1 day
before or 1 week after the elicitation of chronic
dermatitis.
 
Evaluation of the severity of skin symptoms
 
Erythema, edema, scratch marks or erosion and exfolia-
tion were scored on a four-point scale (from 0 to 3,
where 0 was defined as no symptoms, 1 = mild,
2 = moderate and 3 = severe).
 
Measurement of neuropeptide content in skin 
tissues
 
Dorsal mouse skin was placed in 10 mL of 0.5 mol/L
acetate buffer (including 1 
 
µ
 
g/mL aprotinin and 1 
 
µ
 
g/mL
leupeptine), heated at 95
 
°
 
C for 10 min and homoge-
nized. The homogenate was centrifuged at 40 000 
 
g
 
 for
30 min. Then, 2 mL diethyl ether was added to approxi-
mately 10 mL supernatant. After shaking vigorously, the
tube was left to stand and the ether layer was removed.
This procedure was repeated five times and the aqueous
layer was then freeze-dried. The freeze-dried sample was
reconstituted in enzyme immunoassay (EIA) buffer for the
measurement of neuropeptides. Substance P was meas-
ured using the Substance P Enzyme Immunoassay Kit
(Cayman Chemical, Ann Arbor, MI, USA) and calcitonin
gene-related peptide (CGRP) was determined using the
RAT CGRP Enzyme Immunoassay Kit (SPIbio, Messy,
France). Measurements were made using a microplate
reader (model 3550; Bio-Rad, Hercules, CA, USA)
equipped with Microplate Manager III Macintosh data-
analysis software (ver. 1.57; Bio-Rad).
 
Serum IgE measurements
 
After blood collection, serum was separated and stored
at –80
 
°
 
C. The serum was thawed before IgE determina-
tion. A mouse IgE measurement kit (Yamasa EIA;
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Yamasa Shoyu, Chiba, Japan) was used with the micro-
plate reader (model 3550; Bio-Rad).
 
Histopathological analysis
 
Mice were shaved the day before skin tissue collection.
Under anesthesia with Nembutal (sodium pentobarbital;
Dainippon Pharmaceutical, Osaka, Japan), the dorsal
skin was collected, fixed in 10% formalin and paraffin
embedded. Sections (2 
 
µ
 
m) were cut and stained with
hematoxylin–eosin (HE) or Giemsa stain. In addition,
rabbit anti-protein gene product (PGP) 9.5 polyclonal
antibodies (Chemicon International, Temecula, CA,
USA) were used as the anti-PGP9.5 antibodies to stain
nerve fibers.
 
Statistical analysis
 
Results are expressed as the mean 
 
±
 
SEM. Student’s 
 
t
 
-test
was used to compare two groups. In all analyses,
 
P
 
 < 0.05 was considered significant. Statistical analyses
were performed using StatView (SAS Institute, Cary, NC,
USA).
 
R
 
ESULTS
 
Factors promoting AD development in 
individuals with atopic disposition
 
Induction of a contact hypersensitivity reaction to 
TNCB
 
The NC/Nga and DS-Nh mice were sensitized with
TNCB and chronic skin lesions were induced by
repeated local application of TNCB.
Repeated local application of TNCB solution induced
itching skin lesions, together with an increase in levels of
substance P (Fig. 1a) and a decrease in levels of CGRP
(Fig. 1b), changes that were significant in NC/Nga mice
and mild (i.e. not significant) in DS-Nh mice. Serum IgE
levels were not elevated in NC/Nga mice that had not
been treated with TNCB, but were slightly, but not signifi-
cantly, elevated in TNCB-treated NC/Nga mice. In the
case of TNCB-treated DS-Nh mice, serum IgE levels were
augmented considerably more and earlier than untreated
DS-Nh mice (Fig. 2). These serum IgE levels showed no
significant differences. Although the development of skin
lesions was observed at the site of application of TNCB
application on the dorsal area (Fig. 3), lesional skin was
 
Fig. 1
 
Effects of sensitization with 2,4,6-trinitrochlorbenzene (TNCB) on (a)
 
 
 
substance P and (b)
 
 
 
calcitonin gene-related peptide
(CGRP) levels in NC/Nga and DS-Nh mice. Repeated local application of TNCB solution induced skin lesions, together with an
increase in levels of substance P and a decrease in levels of CGRP. ( ), untreated (control); (
 

 
), TNCB treated (+ skin lesions).
Data are the mean 
 
±
 
 SEM. *
 
P
 
 < 0.05 compared with control.
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Fig. 2
 
Effects of sensitization with 2,4,6-trinitrochlorbenzene
(TNCB) on serum IgE levels in NC/Nga and DS-Nh mice. (
 

 
),
DS-Nh mise sensitized with TNCB; (
 

 
), untreated DS-Nh mice;
(
 

 
), NC/Nga mice sensitized with TNCB; (
 

 
), untreated NC/
Nga mice. In DS-Nh mice, early augmentation of IgE produc-
tion was observed compared with untreated mice. Data are the
mean 
 
±
 
 SEM.
 
Fig. 4
 
Effects of mental stress on (a)
 
 
 
neuropeptides (
 

 
, sub-
stance P; 
 

 
, calcitonin gene-related peptide) in the dorsal skin
and (b)
 
 
 
bodyweight of NC/Nga mice (
 

 
, stressed mice; 
 

 
, con-
trol mice) under specific pathogen-free conditions. Twelve mice
were housed in one cage (17 cm 
 
×
 
 15 cm) for 2 weeks. 
 
†
 
Two of
six mice developed skin lesions. Data are the mean 
 
±
 
 SEM.
*
 
P
 
 < 0.05 compared with day 0.
 
Fig. 3
 
Clinical features of skin lesions induced by repeated local application of 2,4,6-trinitrochlorbenzene in NC/Nga and DS-Nh
mice. Symptoms commonly observed in spontaneously developing skin lesions are shown.
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also found on the face and auricles, which did not
receiveany direct application of antigen.
 
Treatment with crowding stress
 
In experiments using NC/Nga mice, substance P and
CGRP levels decreased mildly without significant differ-
ences on day 2 under stress conditions. On day 4,
substance P concentrations increased to levels higher
than before the stress had been induced, whereas levels
of CGRP did not show any change. On day 7, concen-
trations of both substance P and CGRP recovered to
levels seen before the stress had been induced (Fig. 4a).
Serum IgE levels showed no apparent increase under
stress.
However, a loss of bodyweight was observed immedi-
ately after animals were placed under stress (Fig. 4b) and
lesional skin developed in the neck region on day 4
under stress conditions. Skin lesions developed in two of
six mice. No development of new lesional skin was
observed thereafter.
 
Effect of an anti-allergic agent on 
neuropeptide content
 
In DS-Nh mice given the anti-allergic drug olopatadine
hydrochloride on consecutive days starting from the day
before TNCB application, there was a significant
decrease in substance P (Fig. 5a), although no changes
 
Fig. 5
 
Effects of olopatadine on (a)
 
 
 
substance P, (b)
 
 
 
calcitonin gene-related peptide (CGRP), (c)
 
 
 
serum IgE and (d)
 
 
 
skin eruption
score in DS-Nh mice sensitized with 2,4,6-trinitrochlorbenzene (TNCB). Olopatadine was administered every day for 2 weeks from
either 1 day before or 1 week after the elicitation of chronic dermatitis with TNCB. For the skin eruption score, erythema, edema,
scratch marks or erosion and exfoliation were scored on a four-point scale from 0 to 3, where 0 was defined as no symptoms,
1 = mild, 2 = moderate and 3 = severe. (
 

 
), distilled water; ( ), 3 mg/kg olopatadine; (
 

 
), 10 mg/kg olopatadine. Data are the
mean 
 
±
 
 SEM. *
 
P
 
 < 0.05 compared with distilled water.
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in CGRP levels (Fig. 5b) were observed and serum IgE
levels showed no significant difference, but decreased
obviously (Fig. 5c) was observed. Skin lesions were
clearly milder (Fig. 5d). These changes were more defi-
nite in the group given the higher dose of olopatadine
hydrochloride (Fig. 5).
When the administration of olopatadine hydrochloride
was started 1 week after the induction of chronic derma-
titis caused by the repeated application of TNCB solution,
although the severity of the skin lesions was diminished
(Fig. 5d), there were no definite changes on the levels of
substance P (Fig. 5a), CGRP (Fig. 5b) and serum IgE
(Fig. 5c).
 
Histopathological observations
 
When samples of lesional skin tissues, induced by the
repeated application of TNCB, were stained with HE,
marked acanthosis, hyperkeratosis and cellular infiltra-
tion were observed (Fig. 6). When tissues were stained
with Giemsa, an increased number of mast cells and
active degranulation were seen in lesional skin tissues
compared with non-lesional skin tissues (Fig. 7). Using
the anti-PGP9.5 stain, a thickening of cutaneous nerve
fibers in the upper layers of the dermis and elongation of
some nerve fibers to the epidermis were observed
(Fig. 8).
 
Fig. 6
 
Histological features of skin lesions in NC/Nga and DS-Nh mice (hematoxylin–eosin; original magnification 
 
×
 
200). In both
sections, acanthosis of the epidermis, hyperkeratosis and mononulear cell infiltration in the upper dermis were observed.
 
Fig. 7
 
Increases in the number of mast cells and active de-
granulation were observed in lesional skin tissues (lower panel)
induced by repeated application of 2,4,6-trinitrochlorbenzene
compared with non-lesional skin tissues (upper panel) in DS-Nh
mice (Giemsa stain; original magnification 
 
×
 
200).
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D
 
ISCUSSION
 
The NC/Nga mouse strain was developed in 1957
 
4
 
and reported as a murine AD model in 1997.
 
5
 
 These
mice, kept under conventional conditions, are known to
develop skin lesions accompanied by elevated serum IgE
levels from 8 weeks of age, showing intense scratching
behavior resulting in bleeding or even partial loss of
tissues.
The DS/Nh mice were introduced as mice in which
dermatitis occurred spontaneously associated with 
 
Staphy-
lococcus aureus
 
.
 
6
 
 When DS-Nh mice are transferred from
SPF to conventional conditions, 
 
S. aureus
 
 is isolated from
the skin and strongly itching AD-like dermatitis develops
spontaneously, mainly on the face, from 5 weeks of age.
These mice also show elevated IgE levels after 20 weeks
of age. Because the pathology observed in DS-Nh mice
resembles AD, the usefulness of these mice as a model
for AD is attracting attention, as in the case of NC/Nga
mice.
 
7
 
Neuropeptides are small amino acid compounds
contained in the neurons of the brain, spinal cord and
peripheral nerves, where they act as both neuro-
transmitters and neuromodulators.
 
8
 
 Neuropeptides are
present throughout the body and may be produced by
and localized in cells other than those of the central
and peripheral nervous systems. Neuroendocrine cells
in the respiratory tract and skin contain several pep-
tides. In addition, they have been identified in various
inflammatory cells, including eosinophils, mast cells
and mononuclear and polymorphonuclear leukocytes.
Once released, they act on target cells through specific
receptors and are finally degraded into biologically
inactive fragments by several enzymes, namely pepti-
dases.
 
1
 
In the skin, peripheral nerves are abundantly distrib-
uted and more than 20 types of neuropeptides are found.
Substance P and CGRP, released antidromicly from
C-fibers of sensory nerves by epicutaneous stimulation,
lead to vasodilation and the leakage of plasma proteins
and produce erythema and edema. Substance P pro-
motes degranulation of mast cells and the release of
histamine, leukotriene B
 
4
 
 or tumor necrosis factor (TNF)
as an inflammatory cytokine.
 
2
 
 In addition, these neuro-
peptides, directly or indirectly, lead to augmentation
of the expression of adhesion molecules in vascular
endothelial cells and the infiltration of inflammatory cells.
Although abnormal expression of neuropeptides,
especially substance P and CGRP, in the skin of AD
patients has been reported,
 
9,10
 
 there are almost no
reports of quantitative determinations of skin neuro-
peptides levels. The present study provides interesting
data on murine AD, especially results concerning CGRP
levels.
We have compared the neuropeptide content of skin
tissues from NC/Nga, DS-Nh, BALB/c and C57BL/6
mice, aiming to elucidate the relationship between AD
and neuropeptides.11 We have reported that there is an
increase in substance P levels and a decrease in CGRP
levels in skin lesions from NC/Nga mice kept under con-
ventional conditions compared with levels seen in non-
lesional skin in the same mouse strain. Markedly higher
skin levels of substance P were observed in non-lesional
skin of NC/Nga mice kept under conventional conditions
compared with non-lesional skin of the same mouse
strain and the other strains under SPF conditions.
Fig. 8  Thickening of cutane-
ous nerve fibers (arrow) in the
upper layers of the dermis and
some elongating to the epidermis
were observed in lesional skin
tissues induced by repeated
application of 2,4,6-trinitrochlor-
benzene in DS-Nh mice (anti-
protein gene product (PGP) 9.5
stain; original magnification
× 200).
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Some reports have shown an increase in substance
P- and CGRP-containing nerve fibers in the skin of
AD patients.12,13 In contrast, the results of the present
study revealed a paradoxical decrease in CGRP levels,
despite an increase in levels of substance P. The imbal-
ance between substance P and CGRP, which has
immunosuppressive effects, may play an important
role in the development and maintenance of AD-like
dermatitis.
In the present study, chronic contact allergy was
induced by repeated application of TNCB to the dorsal
skin of mice kept under SPF conditions. Histopatho-
logically, acanthosis, hyperkeratosis, cellular infiltration,
increases in the number of mast cells with degranulation
and nerve fibers elongating to the epidermis were
observed in the skin lesions, together with an increase
in IgE, as observed in human AD. It was thought that
chronic contact allergic dermatitis induced by repeated
application of TNCB triggers AD-like skin lesions,
accompanied by augmentation of IgE production.
In skin lesions on the dorsal areas of NC/Nga mice
with chronic dermatitis induced by repeated application
of TNCB, a significant increase in levels of substance P
was observed compared with non-lesional dorsal skin in
untreated mice. In contrast, CGRP levels were signifi-
cantly lower in the skin lesions of TNCB-sensitized NC/
Nga mice compared with non-lesional skin in untreated
mice. Although DS-Nh mice also showed the same
tendency of changes in neuropeptide content, the degree
of change observed in DS-Nh mice was milder than that
seen in NC/Nga mice and not statistically significant. In
DS-Nh mice with chronic dermatitis induced by repeated
application of TNCB, an early and marked increase in
serum IgE levels was observed. However, in untreated
NC/Nga mice, a slight, albeit not significant, increase in
serum IgE levels was observed.
Matsukura et al. have found that the development of
skin eruptions and increases in serum total IgE in DS-Nh
mice are not caused by Th2-predominant mechanisms
but, rather, by Th1-predominant mechanisms through
an increase in the production of interleukin (IL)-13
(S Matsukura et al., unpubl. obs., 2003), whereas NC/
Nga mice have been reported as being a Th2-predomi-
nant AD mouse model in previous studies.14 Therefore,
differences in effects on serum IgE levels between the two
models may reflect differences in the predominance of
Th1 and Th2 mechanisms in these mice. These findings
suggest that the difference in the mechanisms responsible
for the development of skin lesions and the production
of IgE between the two strains is related to changes in
neuropeptides.
We focused on stress, which is known to have impor-
tant direct and indirect effects on various diseases, such
as exacerbation of inflammatory diseases. The word
‘stress’ advocated by Selye15 has taken root as a daily
word with strong psychological implications; however,
in the scientific field, the scope of application of this
word is extremely ambiguous. In stress experiments con-
ducted in animals, physical stress is commonly used as
the stressor, such as restraint, abnormal environmental
temperature and forced exercises including swimming.
However, in the present study, we tried to eliminate the
direct effects of physical treatment and, thus, used
crowding stress, which is defined as a sociopsycho-
logical stress. According to former studies,16–20 crowd-
ing induces weight loss, increased adrenal gland weight
and increased production of monoamine metabolites
(neurotransmitters), all of which are characteristic of
depression and stress.
Accompanying recent advances in immunology, it is
now known that the nervous, endocrine and immune
systems are closely interrelated and regulate body func-
tions via neurotransmitters, hormones and cytokines, and
that this balance is greatly impaired and the immune
system is changed markedly during stress. Hosoi et al.21
reported a correlation between serum corticosterone
levels and immobilization stress. That study also sug-
gested that stress affects the cutaneous immune response.
Furthermore, another report has also indicated that
the psychological state is related, to some extent, to the
immunological state.22
In the study of factors that affect AD, mental stress
induced a transient increase in substance P levels and
development of skin lesions in NC/Nga mice. Because
acute immobilization stress has been reported to
trigger skin mast cell degranulation via corticotropin-
releasing hormone and substance P,23 these results
strongly suggest a relationship between an increase in
substance P induced by stress and the induction of skin
lesions.
In contrast, CGRP levels showed no definite changes
at the time when substance P levels were increased.
Tsuchiya et al.24 reported that immobilization stress did
not influence the cutaneous CGRP content determined by
radioimmunoassay or the number of CGRP-immuno-
reactive nerve fibers in the skin. These facts suggest that
crowding and immobilization-induced stress do not
produce the antidromic mechanism of CGRP in the
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primary afferent nerves of the skin and that the effects of
such stress, if any, are less than that induced by cuta-
neous stimuli, such as aggravating mechanical stimuli or
irritating cold.
The transient increase in substance P levels observed
in the present study supports the hypothesis that the
adaptive phenomenon under chronic stress recovers
the immune function to the prestress state.25
We conducted another study on the effects of an anti-
allergic drug, namely olopatadine hydrochloride, on skin
symptoms and the expression of neuropeptides. Olopat-
adine is a dibenzo-oxepin derivative possessing carboxyl
and amino groups in its molecule and it is a novel anti-
allergic agent developed by Kyowa Hakko Kogyo Co.
Ltd. Olopatadine is a selective histamine H1 receptor
antagonist possessing inhibitory effects on the release of
inflammatory lipid mediators, such as leukotrienes and
thromboxanes, from human polymorphonuclear leuko-
cytes and eosinophils. Olopatadine also inhibits the
tachykininergic contraction in guinea pig bronchi by
prejunctional inhibition of peripheral sensory nerves.26
In addition, further pharmacological actions,26,27 includ-
ing inhibition of eosinophilic infiltration, have been
reported for olopatadine.
In the present study, the development of skin lesions
was clearly inhibited only when the administration of
olopatadine was started before the elicitation of chronic
dermatitis caused by the repeated application of TNCB.
Substance P levels in skin tissues were markedly
suppressed in mice given the high dose of olopatadine.
However, when the drug was administered after skin
lesions had developed, although the skin lesions dimin-
ished, there was no clear effect on levels of substance P in
the skin tissues. These results suggest significant involve-
ment of substance P in the pathogenesis of AD. Further-
more, some of the effect of olopatadine on the
development of AD may be due to the suppression of
substance P.
In conclusion, it is suggested that repeated contact
allergic dermatitis or mental stress may promote the
development and exacerbation of AD and that substance
P has a role in the response. In addition, it seems that an
anti-allergic drug, such as olopatadine hydrochloride,
possibly downregulates substance P and thereby sup-
presses the development of AD. In the future, the
development and clinical application of drugs strongly
influencing the release of neuropeptides like substance P
and the expression of neuropeptide receptors would be
expected for the treatment of AD.
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